β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Cited by (1,000)

Items 101–200 of 1,000

  1. Positive and negative regulation of EAAT2 by NF‐κB: a role for N‐myc in TNFα‐controlled repression
    R. Sitcheran, P. Gupta, P. Fisher, A. Baldwin · 2005 · The EMBO Journal
  2. Role of Astrocytes in Epilepsy
    Douglas A. Coulter, Christian Steinhäuser · 2015 · Cold Spring Harbor Perspectives in Medicine
  3. An astroglial basis of major depressive disorder? An overview
    Wang, Qian, Jie, Wei, Liu, Ji‐Hong, Yang, Jian‐Ming, Gao, Tian‐Ming · 2017 · Glia
  4. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport
    Sara K. Custer, Gwenn A. Garden, Nishi Gill, Udo Rueb, Randell T. Libby, Christian Schultz, Stephan J. Guyenet, Thomas Deller, Lesnick E. Westrum, Bryce L. Sopher et al. · 2006 · Nature Neuroscience
  5. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis
    Makoto Urushitani, Samer Abou Ezzi, Jean‐Pierre Julien · 2007 · Proceedings of the National Academy of Sciences
  6. From Pathophysiology to Novel Antidepressant Drugs: Glial Contributions to the Pathology and Treatment of Mood Disorders
    Sanacora, Gerard, Banasr, Mounira · 2013 · Biological Psychiatry
  7. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies.
    A. Hazell · 2007 · Neurochemistry International
  8. Pathophysiological and diagnostic implications of cortical dysfunction in ALS
    Nimeshan Geevasinga, Parvathi Menon, P. Hande Özdi̇nler, Matthew C. Kiernan, Steve Vucic · 2016 · Nature Reviews Neurology
  9. Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1
    Yang, Yongjie, Gozen, Oguz, Watkins, Andrew, Lorenzini, Ileana, Lepore, Angelo, Gao, Yuanzheng, Vidensky, Svetlana, Brennan, Jean, Poulsen, David, Won Park, Jeong et al. · 2009 · Neuron
  10. Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke
    Elaine Besancon, Shuzhen Guo, Josephine M. Lok, Michael Tymianski, Eng H. Lo · 2008 · Trends in Pharmacological Sciences
  11. Drug repositioning for orphan diseases
    Sardana, D., Zhu, C., Zhang, M., Gudivada, R. C., Yang, L., Jegga, A. G. · 2011 · Briefings in Bioinformatics
  12. Glutamatergic Modulators: The Future of Treating Mood Disorders?
    Zarate, Carlos, Machado-Vieira, Rodrigo, Henter, Ioline, Ibrahim, Lobna, Diazgranados, Nancy, Salvadore, Giacomo · 2010 · Harvard Review of Psychiatry
  13. Novel Drugs and Therapeutic Targets for Severe Mood Disorders
    Sanjay J. Mathew, Husseini K. Manji, Dennis S. Charney · 2008 · Neuropsychopharmacology
  14. Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies
    Steve Vucic, Jeffrey D. Rothstein, Matthew C. Kiernan · 2014 · Trends in Neurosciences
  15. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: Involvement of oxidative stress and mitogen-activated protein kinase cascades
    Marco Matos, Elisabete Augusto, Catarina Resende Oliveira, Paula M. Agostinho · 2008 · Neuroscience
  16. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder
    Christopher Pittenger, John Harrison Krystal, Vladimir Coric · 2006 · NeuroRx
  17. Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks
    Stephen M. Strittmatter · 2014 · Nature Medicine
  18. Astrocytic dysfunction: Insights on the role in neurodegeneration
    Daniela Rossi, Andrea Volterra · 2009 · Brain Research Bulletin
  19. Finding New Tricks For Old Drugs: An Efficient Route For Public-Sector Drug Discovery
    Kerry Ann O'Connor, Bryan L. Roth · 2005 · Nature Reviews Drug Discovery
  20. Recent progress of drug nanoformulations targeting to brain
    Abdur Rauf Khan, Xiaoye Yang, Manfei Fu, Guangxi Zhai · 2018 · Journal of Controlled Release
  21. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition
    Miller, Oliver H., Moran, Jacqueline T., Hall, Benjamin J. · 2016 · Neuropharmacology
  22. Life cycle of translational research for medical interventions
    Contopoulos-Ioannidis, Despina G., Alexiou, George A., Gouvias, Theodore C., Ioannidis, John P. A. · 2008 · Science
  23. Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease
    Kou Takahashi, Joshua B. Foster, Chien‐liang Glenn Lin · 2015 · Cellular and Molecular Life Sciences
  24. Inhibition of Angiogenesis by the Antifungal Drug Itraconazole
    Chong, Curtis R., Xu, Jing, Lu, Jun, Bhat, Shridhar, Sullivan, David J., Liu, Jun O. · 2007 · ACS Chemical Biology
  25. Thinking Outside the Cleft to Understand Synaptic Activity: Contribution of the Cystine-Glutamate Antiporter (System xc−) to Normal and Pathological Glutamatergic Signaling
    Bridges, Richard, Lutgen, Victoria, Lobner, Doug, Baker, David A. · 2012 · Pharmacological Reviews
  26. The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
    Jennifer L. Shoemaker, Kathryn A. Seely, Ronald L. Reed, John P. Crow, Paul L. Prather · 2007 · Journal of Neurochemistry
  27. The truth about antibiotics
    Grace Yim, Helena Huimi Wang, JULIAN E. DAVIES · 2006 · International Journal of Medical Microbiology
  28. Dual roles of astrocytes in plasticity and reconstruction after traumatic brain injury
    Yunxiang Zhou, Anwen Shao, Yihan Yao, Sheng Tu, Yongchuan Deng, Jianmin Zhang · 2020 · Cell Communication and Signaling
  29. Modelling amyotrophic lateral sclerosis: progress and possibilities
    Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch · 2017 · Disease Models & Mechanisms
  30. Seizures and gliomas — towards a single therapeutic approach
    Gilles Huberfeld, Charles J. Vecht · 2016 · Nature Reviews Neurology
  31. Molecular dialogs between the ischemic brain and the peripheral immune system: Dualistic roles in injury and repair
    Chengrui An, Yejie Shi, Peiying Li, Xiaoming Hu, Yu Gan, Ruth Anne Stetler, Rehana K. Leak, Yanqin Gao, Bao‐liang Sun, Ping Zheng et al. · 2014 · Progress in Neurobiology
  32. Drug repositioning and repurposing for Alzheimer disease
    Ballard, Clive, Aarsland, Dag, Cummings, Jeffrey, O’Brien, John, Mills, Roger, Molinuevo, Jose Luis, Fladby, Tormod, Williams, Gareth, Doherty, Pat, Corbett, Anne et al. · 2020 · Nature Reviews Neurology
  33. Upregulation of Glt1 Attenuates Cue-Induced Reinstatement of Cocaine-Seeking Behavior in Rats
    Youssef Sari, Kathryn D. Smith, Pir K. Ali, George V. Rebec · 2009 · Journal of Neuroscience
  34. Expression of ALS‐linked TDP‐43 mutant in astrocytes causes non‐cell‐autonomous motor neuron death in rats
    Jianbin Tong, Cao Huang, Fangfang Bi, Qinxue Wu, Bo Huang, Xionghao Liu, Fang Li, Hongxia Zhou, Xu‐Gang Xia · 2013 · The EMBO Journal
  35. Using glutamate homeostasis as a target for treating addictive disorders
    Kathryn J. Reissner, Peter W. Kalivas · 2010 · Behavioural Pharmacology
  36. ALS: A bucket of genes, environment, metabolism and unknown ingredients
    Mónica Zufiría, Francisco Javier Gil-Bea, Roberto Fernández‐Torrón, Juan José Poza, José Luís Muñoz-Blanco, Ricard Rojas‐García, Javier Riancho, Adolfo López de Munaín · 2016 · Progress in Neurobiology
  37. Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control
    Nicole M. Rowley, Karsten K. Madsen, Arne Schousboe, H. Steve White · 2012 · Neurochemistry International
  38. Neuroprotective agents for clinical trials in ALS
    Bryan J. Traynor, Lucie I. Bruijn, ROBIN A. CONWIT, Flint M. Beal, Gilmore N. O’Neill, Susan C. Fagan, Merit Cudkowicz · 2006 · Neurology
  39. Excitotoxicity and Amyotrophic Lateral Sclerosis
    P. van Cutsem, Maarten Dewil, Wim Robberecht, Ludo Van Den Bosch · 2005 · Neurodegenerative Diseases
  40. Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation
    Kon Chu, Soon‐Tae Lee, Dong-In Sinn, Song‐Yi Ko, Eun‐Hee Kim, Jeong‐Min Kim, Se‐Jeong Kim, Dong-Kyu Park, Keun‐Hwa Jung, Eun‐Cheol Song et al. · 2006 · Stroke
  41. Neuron-Astrocyte Interactions in Parkinson’s Disease
    Miyazaki, Ikuko, Asanuma, Masato · 2020 · Cells
  42. Mechanisms of Epileptogenesis in Tuberous Sclerosis Complex and Related Malformations of Cortical Development with Abnormal Glioneuronal Proliferation
    Michael L. Wong · 2007 · Epilepsia
  43. Neurotransmitter transporters expressed in glial cells as regulators of synapse function
    Volker Eulenburg, Jesús Gomeza · 2010 · Brain Research Reviews
  44. Ceftriaxone Treatment after Traumatic Brain Injury Restores Expression of the Glutamate Transporter, GLT-1, Reduces Regional Gliosis, and Reduces Post-Traumatic Seizures in the Rat
    Grant S. Goodrich, Anatoli Y. Kabakov, Mustafa Qadir Hameed, Sameer C. Dhamne, Paul A. Rosenberg, Alexander Rotenberg · 2013 · Journal of Neurotrauma
  45. mda-7/IL-24: Multifunctional cancer-specific apoptosis-inducing cytokine
    Pankaj Gupta, Zhao Zhong Su, Irina V. Lebedeva, Devanand Sarkar, Moira Sauane, Luni Emdad, Michael A. Bachelor, Steven Grant, David T. Curiel, Paul Dent · 2006 · Pharmacology & Therapeutics
  46. The endocannabinoid system as a target for the treatment of neurodegenerative disease
    Emma L. Scotter, Mary E. Abood, Michelle Glass · 2010 · British Journal of Pharmacology
  47. Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression
    Zink, M., Vollmayr, B., Gebicke-Haerter, P.J., Henn, F.A. · 2010 · Neuropharmacology
  48. Riluzole in the Treatment of Mood and Anxiety Disorders
    Pittenger, Christopher, Coric, Vladimir, Banasr, Mounira, Bloch, Michael, Krystal, John H, Sanacora, Gerard · 2008 · CNS Drugs
  49. Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death
    Daniela Rossi · 2015 · Progress in Neurobiology
  50. Focal degeneration of astrocytes in amyotrophic lateral sclerosis
    Rossi, D, Brambilla, L, Valori, C F, Roncoroni, C, Crugnola, A, Yokota, T, Bredesen, D E, Volterra, A · 2008 · Cell Death & Differentiation
  51. Astrogliosis as a therapeutic target for neurodegenerative diseases
    Anna Maria Colangelo, Lilia Alberghina, Michèle Papa · 2014 · Neuroscience Letters
  52. Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxonein vitro
    Jan Lewerenz, Philipp Albrecht, Mai‐Ly Tran Tien, Nadine Henke, Saravanan Karumbayaram, Harley I. Kornblum, Martina Wiedau‐Pazos, Dave Schubert, Pamela A Maher, Axel Methner · 2009 · Journal of Neurochemistry
  53. The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)
    Redler, Rachel L., Dokholyan, Nikolay V. · 2012 · Progress in Molecular Biology and Translational Science
  54. Ischemia, Immunosuppression and Infection—Tackling the Predicaments of Post-Stroke Complications
    Raymond Shim, Connie H. Y. Wong · 2016 · International Journal of Molecular Sciences
  55. The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders
    Machado-Vieira, Rodrigo, Manji, Husseini K., Zarate, Carlos A. · 2009 · The Neuroscientist
  56. Current approaches to enhance glutamate transporter function and expression
    Andréia C. K. Fontana · 2015 · Journal of Neurochemistry
  57. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis
    Martin R. Turner, Robert P. Bowser, Lucie I. Bruijn, Luc Dupuis, Albert Christian Ludolph, Michael S. McGrath, Giovanni Manfredi, Nicholas John Maragakis, Robert G. Miller, Seth L. Pullman et al. · 2013 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  58. Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System
    Malik, Anna R., Willnow, Thomas E. · 2019 · International Journal of Molecular Sciences
  59. Vesicular and Plasma Membrane Transporters for Neurotransmitters
    Blakely, R. D., Edwards, R. H. · 2012 · Cold Spring Harbor Perspectives in Biology
  60. Astroglial glutamate transporters in the brain: Regulating neurotransmitter homeostasis and synaptic transmission
    Ciaran Murphy‐Royal, Julien Pierre Dupuis, Laurent Groc, Stéphane H. R. Oliet · 2017 · Journal of Neuroscience Research
  61. Primary Cultures of Astrocytes: Their Value in Understanding Astrocytes in Health and Disease
    Sofie C. Lange, Lasse K. Bak, Helle S. Waagepetersen, Arne Schousboe, Michael D. Norenberg · 2012 · Neurochemical Research
  62. Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides
    Reglodi, Dora, Renaud, Justine, Tamas, Andrea, Tizabi, Yousef, Socías, Sergio B., Del-Bel, Elaine, Raisman-Vozari, Rita · 2017 · Progress in Neurobiology
  63. GLT-1-Dependent Disruption of CNS Glutamate Homeostasis and Neuronal Function by the Protozoan Parasite Toxoplasma gondii
    Clément N. David, Elma S. Frias, Jenny I. Szu, Philip A. Vieira, Jacqueline A. Hubbard, Jonathan W. Lovelace, Michael Marena, Danielle Worth, Kathryn E. McGovern, Iryna M. Ethell et al. · 2016 · PLoS Pathogens
  64. Targeting Astrocytes for Stroke Therapy
    Yanxin Zhao, David A. Rempe · 2010 · Neurotherapeutics
  65. Synaptic Glutamate Spillover Due to Impaired Glutamate Uptake Mediates Heroin Relapse
    Haowei Shen, Michael D. Scofield, Heather A. Boger, Megan E. Hensley-Simon, Peter W. Kalivas · 2014 · Journal of Neuroscience
  66. Brains and Brawn: Toxoplasma Infections of the Central Nervous System and Skeletal Muscle
    Elizabeth A. Wohlfert, Ira J. Blader, Emma H. Wilson · 2017 · Trends in Parasitology
  67. Transgenic mouse models of amyotrophic lateral sclerosis
    Jean‐Pierre Julien, Jasna Križ · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  68. Reversal of morphine-induced cell-type–specific synaptic plasticity in the nucleus accumbens shell blocks reinstatement
    Matthew C. Hearing, Jakub Jedynak, Stephanie R. Ebner, Anna E. Ingebretson, Anders J. Asp, Rachel A. Fischer, Clare E. Schmidt, Erin B. Larson, Mark John Thomas · 2016 · Proceedings of the National Academy of Sciences
  69. Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging
    Jasmin K. Hefendehl, Jeffrey M. LeDue, Rebecca W.Y. Ko, Jasmin Mahler, Timothy H. Murphy, Brian A. MacVicar · 2016 · Nature Communications
  70. Effective Treatment of Manganese-Induced Occupational Parkinsonism With p-Aminosalicylic Acid: A Case of 17-Year Follow-Up Study
    Yue‐Ming Jiang, Xuean Mo, DU Feng-qi, Xue Fu, Xiayan Zhu, Hong-Yu Gao, Jinlan Xie, Feng-Ling Liao, Enrico Pira, Wei Zheng · 2006 · Journal of Occupational and Environmental Medicine
  71. Neuron–astrocyte signaling and epilepsy
    Gerald Seifert, Christian Steinhäuser · 2011 · Experimental Neurology
  72. Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications
    Cozzolino, Mauro, Ferri, Alberto, Teresa Carrì, Maria · 2008 · Antioxidants & Redox Signaling
  73. Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection
    Kong, Qiongman, Chang, Ling-Chu, Takahashi, Kou, Liu, Qibing, Schulte, Delanie A., Lai, Liching, Ibabao, Brian, Lin, Yuchen, Stouffer, Nathan, Mukhopadhyay, Chitra Das et al. · 2014 · Journal of Clinical Investigation
  74. Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression
    Wenxue Liu, Jing Wang, Ze-Min Xie, Ning Xu, Guang-Fen Zhang, Min Jia, Zhiqiang Zhou, Kenji Hashimoto, Jianjun Yang · 2015 · Psychopharmacology
  75. Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS
    Jung-Hee Lee, Seung Jae Hyeon, Hyeonjoo Im, Hyun Ryu, Yunha Kim, Hoon Ryu · 2016 · Experimental Neurobiology
  76. Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia
    Chew, Li-Jin, Fusar-Poli, Paolo, Schmitz, Thomas · 2013 · Developmental Neuroscience
  77. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease
    Joannee Zumkehr, Carlos J. Rodríguez‐Ortiz, David Cheng, Zanett Kieu, Thin Wai, Charlesice Hawkins, Jason Kilian, Sharon Lim, Rodrigo Medeiros, Masashi Kitazawa · 2015 · Neurobiology of Aging
  78. Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques
    Mehdi A. J. van den Bos, Nimeshan Geevasinga, Mana Higashihara, Parvathi Menon, Steve Vucic · 2019 · International Journal of Molecular Sciences
  79. Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development
    Green, Jennifer Leigh, dos Santos, Wagner Ferreira, Fontana, Andréia Cristina Karklin · 2021 · Biochemical Pharmacology
  80. Antidepressant-Like Effects of Ceftriaxone in Male C57BL/6J Mice
    Yann S. Mineur, Marina R. Picciotto, Gerard Sanacora · 2006 · Biological Psychiatry
  81. Milestone Review: Metabolic dynamics of glutamate and GABA mediated neurotransmission — The essential roles of astrocytes
    Jens Velde Andersen, Arne Schousboe · 2023 · Journal of Neurochemistry
  82. “Targeting astrocytes in CNS injury and disease: A translational research approach”
    Angela R. Filous, Jerry Silver · 2016 · Progress in Neurobiology
  83. Neuroprotective potential of ceftriaxone in in vitro models of stroke
    Janusz Lipski, C.K. Wan, Ji‐Zhong Bai, Rongbiao Pi, D. Li, D. Donnelly · 2007 · Neuroscience
  84. The Glutamate/ GABA ‐Glutamine Cycle: Insights, Updates, and Advances
    Jens Velde Andersen · 2025 · Journal of Neurochemistry
  85. The Immunobiology of Tourette's Disorder, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus , and Related Disorders: A Way Forward
    Tanya K. Murphy, Roger Kurlan, James Frederick Leckman · 2010 · Journal of Child and Adolescent Psychopharmacology
  86. Glutamate Transporter EAAT2: A New Target For The Treatment Of Neurodegenerative Diseases
    Chien‐liang Glenn Lin, Qiongman Kong, Gregory D. Cuny, Marcie A. Glicksman · 2012 · Future Medicinal Chemistry
  87. Molecular and Cellular Mechanisms Affected in ALS
    Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya Geetha Vijayakumar, William John Duddy, Stéphanie Duguez · 2020 · Journal of Personalized Medicine
  88. Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders
    Douglas Roberts-Wolfe, Peter W. Kalivas · 2015 · CNS & Neurological Disorders - Drug Targets
  89. Protecting Motor Neurons from Toxic Insult by Antagonism of Adenosine A2a and Trk Receptors
    Jelena Mojsilovic‐Petrovic, Goo‐Bo Jeong, Amanda J. Crocker, Amrita Arneja, Samuel David, David Russell, Robert Gordon Kalb · 2006 · Journal of Neuroscience
  90. Astrocytes as new targets to improve cognitive functions
    Glenn M. Dallérac, Nathalie Rouach · 2016 · Progress in Neurobiology
  91. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells
    Zhao-zhong Su, Luni Emdad, Moira Sauane, Irina V. Lebedeva, Devanand Sarkar, Pankaj Gupta, Charles David James, Aaron L. Randolph, Kristoffer C. Valerie, Mark R. Walter et al. · 2005 · Oncogene
  92. Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration
    Christopher M. Henstridge, Makis Tzioras, Rosa Chiara Paolicelli · 2019 · Frontiers in Cellular Neuroscience
  93. Estrogen and tamoxifen reverse manganese‐induced glutamate transporter impairment in astrocytes
    Eun-Sook Lee, Marta Sidoryk‐Wȩgrzynowicz, Haiyan Jiang, Zhaobao Yin, Michael Aschner · 2009 · Journal of Neurochemistry
  94. Target Identification for CNS Diseases by Transcriptional Profiling
    C. Anthony Altar, Marquis P. Vawter, Stephen D. Ginsberg · 2008 · Neuropsychopharmacology
  95. Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis
    Ronald Kim, Kati L. Healey, Marian T. Sepulveda-Orengo, Kathryn J. Reissner · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  96. Targeting glutamate uptake to treat alcohol use disorders
    Rao, P.S.S., Bell, Richard L., Engleman, Eric A., Sari, Youssef · 2015 · Frontiers in Neuroscience
  97. Glial Dysfunction in the Mouse Habenula Causes Depressive-Like Behaviors and Sleep Disturbance
    Cui, Wanpeng, Mizukami, Hiroaki, Yanagisawa, Michiko, Aida, Tomomi, Nomura, Masatoshi, Isomura, Yoshikazu, Takayanagi, Ryoichi, Ozawa, Keiya, Tanaka, Kohichi, Aizawa, Hidenori · 2014 · The Journal of Neuroscience
  98. Differential Promotion of Glutamate Transporter Expression and Function by Glucocorticoids in Astrocytes from Various Brain Regions
    Jürgen Zschocke, Nadhim Bayatti, Albrecht Martin Clement, Heidrun Witan, Maciej Figiel, Jürgen Engele, Christian Behl · 2005 · Journal of Biological Chemistry
  99. Ceftriaxone, a Beta-Lactam Antibiotic, Reduces Ethanol Consumption in Alcohol-Preferring Rats
    Youssef Sari, M. Sakai, Jason M. Weedman, George V. Rebec, Richard L. Bell · 2011 · Alcohol and Alcoholism
  100. Delayed Disease Onset and Extended Survival in the SOD1G93ARat Model of Amyotrophic Lateral Sclerosis after Suppression of Mutant SOD1 in the Motor Cortex
    Gretchen M. Thomsen, Genevíève Gowing, Jessica Latter, Maximus Chen, Jean‐Philippe Vit, Kevin Staggenborg, Pablo Avalos, Mor R. Alkaslasi, Laura Ferraiuolo, Shibi B. Likhite et al. · 2014 · Journal of Neuroscience